Chemicals & Allied Products · SIC 2800

INNOSPEC INC.

IOSP

Watch

Latest revenue

$453.2M

as of 2026-03-31

Latest net income

$30.4M

as of 2026-03-31

Net margin

6.7%

as of 2026-03-31

Community sentiment

Where do you think IOSP is heading?

1 month
6 months
12 months
5 years
Sign in free to vote and see community sentiment

Keep private notes on IOSP — thesis, target price, catalysts to watch.

Visible only to you. Never shared. Never used to train AI.

Sign in to add your own notes

IOSP vs S&P 500 · rebased to 100

-2.0% / yr 21.7 pts / yr vs S&P 500(S&P 500 +19.7% / yr) 7.6% total
Compare:

Market data

Price feed temporarily unavailable for IOSP.

What this company does

AI

Item 1 Business When we use the terms “Innospec,” “the Corporation,” “the Company,” “Registrant,” “we,” “us” and “our,” we are referring to Innospec Inc. and its consolidated subsidiaries unless otherwise indicated or the context otherwise requires. General Innospec develops, manufactures, blends, markets and supplies a wide range of specialty chemicals to customers in the Americas, Europe, the Middle East, Africa and Asia-Pacific. Our Performance Chemicals business creates innovative technology-based solutions for the personal care, home care, agrochemical, construction, mining and other industrial markets. Our Fuel Specialties business specializes in manufacturing and supplying fuel…

AI summary unavailable — showing raw filing excerpt

Generated from IOSP's filing dated 2026-02-18

Key risks

AI

Item 1A Risk Factors The factors described below represent the principal risks associated with our business. Global Conditions Competition and market conditions may adversely affect our operating results. In certain markets, our competitors are larger than us and may have greater access to financial, technological and other resources. As a result, competitors may be better able to adapt to changes in conditions in our industries, fluctuations in the costs of raw materials or changes in global economic conditions. Competitors may also be able to introduce new products with enhanced features that may cause a decline in the demand and sales of our products. Consolidation of customers or…

AI summary unavailable — showing raw filing excerpt

Generated from IOSP's filing dated 2026-02-18

7.2
of 10

ActaClear Score

Above avg
#2 of 16 in Chemicals & Allied Products
+0.0 · 5d
Profitability·25%
6.0
Growth·15%
8.7
Value·20%
8.7
Quality·20%
Momentum·20%
6.0

Computed from 5 years of SEC fundamentals + latest market data, ranked within Chemicals & Allied Products (16 peers). 10 = best in industry, 5 = median, 0 = worst. Refreshed Jun 10, 2026.